Social Pharmacology and its impact on clinics
- PMID: 34975130
- PMCID: PMC8764975
- DOI: 10.4103/ijp.ijp_867_21
Social Pharmacology and its impact on clinics
Conflict of interest statement
None
Figures
Similar articles
-
The global alliance for pediatric pharmacology: the future is here and now.Paediatr Drugs. 2009;11(1):4-5. doi: 10.2165/0148581-200911010-00002. Paediatr Drugs. 2009. PMID: 19127940
-
The Journal of Clinical Pharmacology, Clinical Pharmacology in Drug Development, and the Impact Factor.J Clin Pharmacol. 2017 May;57(5):545-546. doi: 10.1002/jcph.909. J Clin Pharmacol. 2017. PMID: 28409839 No abstract available.
-
Pharmacology 2.0.Br J Clin Pharmacol. 2013 Nov;76(5):625-9. doi: 10.1111/bcp.12088. Br J Clin Pharmacol. 2013. PMID: 23362953 Free PMC article. No abstract available.
-
The quest for a cure.Annu Rev Pharmacol Toxicol. 1993;33:1-23. doi: 10.1146/annurev.pa.33.040193.000245. Annu Rev Pharmacol Toxicol. 1993. PMID: 8494337 Review. No abstract available.
-
Clinical pharmacology education: looking into the future.Clin Pharmacol Ther. 2007 Feb;81(2):305-8. doi: 10.1038/sj.clpt.6100068. Clin Pharmacol Ther. 2007. PMID: 17259956 Review.
References
-
- Alloza JL. Social pharmacology: Conceptual remarks. Drug Inf J. 2004;38:321–9.
-
- Alloza JL. Social pharmacology: A further step in public health. Open Soc Sci J. 2014;6:8–15.
-
- Montastruc JL. Social pharmacology: A new topic in clinical pharmacology. Therapie. 2002;57:420–6. - PubMed
-
- Penick SB, Fisher S. Drug-set interaction: Psychological and physiological effects of epinephrine under differential expectations. Psychosom Med. 1965;27:177–82. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources